Drug Trial Radar · NCT03007160
A Study on the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence
Last checked: Nov 20, 2026Latest source record: Feb 1, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,001
Planned (sponsor's estimate)
Start
Jul 2016
Primary completion
Sep 2020
Study completion Sep 2020
Sponsor
- Lead sponsor
- Dawnrays Pharmaceutical (Holdings) LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jan 2, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Assess the efficacy and safety of potassium citrate extended-release tablets on Urolithiasis formation or recurrence.
Conditions
- Urolithiasis
Interventions
Potassium Citrate Extended-release TabletsDrug
Daily 3.24g, Po ,Tid, each 1.08g/tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Urolithiasis recurrenceTime frame: through study completion, an average of 1 year
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
The Fifth Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China · Recruiting
The Second Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Recruiting
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
Wuhan No.1 Hospital(Wuhan Integrated TCM & Western Medicine Hospital)
Wuhan, Hubei, China · Active not recruiting
Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China · Recruiting
Zhejiang Xiaoshan Hospital
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.